Downtown Women's Healthcare

Denver, Colorado 80218

0 studies enrolling now · 34 studies all time

What they study most

Anemia, Atrophic Vaginitis, Atrophic Vaginitis Due to Menopause, Bacterial Vaginosis, Contraception, Dyspareunia, Female Orgasmic Disorder, Female Sexual Arousal Disorder, Genital Warts, Hot Flashes, Hot Flushes, Leiomyomas

Studies at this site

• A Study to Find Out How Safe Long-term Treatment With Fezolinetant is in Women With Hot Flashes Going Through Menopause — Completed
• A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through Menopause - 2 — Completed
• Study to Evaluate the Equivalence of Estradiol Vaginal Cream to Reference Standard in the Treatment of Vaginal Atrophy — Completed
• A Study to Assess the Safety of a New Inserter Device for Paragard® (Intrauterine Copper Contraceptive) — Completed
• DARE-BV1 in the Treatment of Bacterial Vaginosis (DARE-BVFREE) — Completed
• Study of Contraceptive Efficacy & Safety of Phexxi™ (Previously Known as Amphora) Gel Compared to Conceptrol Vaginal Gel — Completed
• A Comparison of Estradiol Vaginal Cream to Estrace® Cream in 350 Postmenopausal Females With Atrophic Vaginitis — Completed
• A Trial to Investigate Efficacy, Safety and Tolerability of FE 201836 for Nocturia Due to Nocturnal Polyuria in Adults — Completed
• Multi-Center Study to Evaluate the Efficacy and Safety of Sildenafil Cream (3.6%) in Premenopausal Patients With Female Sexual Arousal Disorder — Status unconfirmed
• Multi-Center Study of New Medications to Treat Vaginal Infections — Completed
• Multi-Center Study of New Medications to Treat Vaginal Infections — Completed
• Multi-Center Study of New Medications to Treat Vaginal Infections — Completed
• Safety, Efficacy, Tolerability and Pharmacokinetics of LF111 (Drospirenone 4.0 mg) During 13 Cycles — Completed
• Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV) — Completed
• Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003 — Completed
• Dose Ranging Study of SPL7013 Gel for Treatment of Bacterial Vaginosis (BV) — Completed
• A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms — Completed
• Efficacy and Safety of TBS-2 Testosterone Gel in Women With Acquired Female Orgasmic Disorder — Completed
• Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women — Completed
• An Extension Study Investigating the Efficacy and Safety of a Fast-Dissolving ("Melt") Formulation of Desmopressin for the Treatment of Nocturia in Adults — Completed
• Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia — Completed
• 24-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms — Completed
• Efficacy/Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms (VMS) — Completed
• Evaluating the Safety and Efficacy of Proellex® (CDB-4124) in Premenopausal Women With Symptomatic Uterine Fibroids — Stopped early
• Safety and Efficacy of Proellex in Pre-menopausal Anemic Women With Symptomatic Uterine Fibroids — Stopped early
• Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids — Completed
• Study to Evaluate the Safety and Bioequivalence of Estradiol Vaginal Inserts, 10 mcg and Vagifem® 10 mcg and Compare to Placebo — Completed
• Efficacy and Safety Study of Ulipristal Acetate in Females With Anemia Associated With Uterine Leiomyoma — Withdrawn before enrolling
• Estradiol Transdermal Spray in the Treatment of Vasomotor Symptoms — Completed
• A Study of MF101 in Postmenopausal Women — Status unconfirmed
• A Study of Tranexamic Acid (XP12B) in Women With Heavy Menstrual Bleeding — Completed
• Phase 3 Study of Imiquimod Creams in the Treatment of External Genital Warts — Completed
• Dose Ranging Study of Metronidazole Vaginal Gel in the Treatment of Bacterial Vaginosis — Completed
• Evaluate the Safety and Efficacy of Bremelanotide in Women With Female Sexual Arousal Disorder (FSAD) — Completed